Background: Neurocognitive dysfunction remains a limitation of cardiac surgery with cardiopulmonary bypass. Intraoperative cerebral microembolization is believed to be one of the most important etiologic factors. Using a new generation of transcranial Doppler ultrasonography, we compared the number and nature of intraoperative microemboli in patients undergoing on-pump and off-pump cardiac surgery procedures.
C erebral injury is a major cause of mortality and morbidity after cardiac surgery and occurs in 2 distinct forms. Overt injury, usually a stroke, occurs in 3% of patients undergoing coronary artery bypass grafting (CABG), whereas injury leading to cognitive impairment, only evident on detailed neuropsychologic testing, [1] [2] [3] occurs in up to 80% of all patients soon after surgery and persists in one quarter of these at 6 months. 4 Early postoperative cognitive impairment correlates with later progression of cognitive decline and impaired quality of life. 5, 6 Cardiopulmonary bypass (CPB) can cause brain injury through several mechanisms, but microembolization is believed to be the most important. Pugsley and colleagues 7 demonstrated that postoperative neuropsychologic deficits are related to the number of cerebral microemboli after routine CPB.
High-intensity transient signals (HITS), detected using transcranial Doppler (TCD) ultrasonography, result from an increase in the ultrasound signal reflected from the microemboli compared with the surrounding blood and can provide an index of microemboli entering the cerebral circulation. However, an increase in the ultrasound signal can also result from artifacts caused by movement. Until recently, it was not possible to differentiate objectively between artifacts and emboli or to discriminate between solid and gaseous microemboli. With the availability of a multifrequency TCD system (EmboDop; DWL Elektronische Systeme GmbH, Singen, Germany), online artifact rejection and automatic discrimination between solid and gaseous microemboli are now achievable with high sensitivity and specificity. 8, 9 This technique depends on insonating an embolus using 2 different frequencies. A solid embolus would reflect more ultrasound at the higher compared with the lower frequency, whereas the opposite occurs with gaseous microemboli. This study quantified the number and nature of intraoperative microemboli in patients undergoing various cardiac surgery procedures.
Material and Methods

Patient Groups
A total of 45 patients undergoing first-time cardiac surgery were prospectively recruited for the study. All patients gave informed consent, and full ethical approval was obtained from the local research ethics committee (Oxford Research Ethics Committee number C01.258). The patients were divided into 3 groups. Fifteen patients underwent off-pump CABG (OPCABG), 15 patients underwent on-pump CABG (ONCABG), and the remaining 15 patients underwent valve replacement with or without CABG: aortic valve replacement (12 patients), aortic valve replacement and CABG (2 patients), and mitral valve replacement and CABG (1 patient). Patients with symptomatic carotid disease or atrial fibrillation were excluded.
CPB
After full anticoagulation with heparin given at a dose of 300 IU/kg to maintain an activated clotting time of 400 to 600 seconds, CPB was instituted using ascending aortic cannulation and a 2-stage right atrial venous cannulation. A roller pump (Jostra HL 20, Hirrlingen, Germany) and hollow-fiber membrane oxygenator (Affinity NT; Medtronic Inc, Minneapolis, Minn) were used. The extracorporeal circuit was primed with 1000 mL of Hartmann's solution and 2500 IU of heparin. CPB was maintained with nonpulsatile flow with a flow rate of 2.4 L/m 2 /min at normothermia with the temperature allowed to drift to 34°C. Arterial line filtra- tion was not used. Cardiotomy suction was used. Acid-base was managed with alpha stat control. Myocardial protection was achieved with intermittent antegrade cold crystalloid cardioplegia. On completion of all distal anastomoses, the aortic crossclamp was removed, and the proximal anastomosis was performed with partial aortic clamping.
Off-Pump Technique
Complete anticoagulation with heparin was achieved as in the CPB group. Regional myocardial immobilization was achieved with a suction stabilizer (Octopus, Medtronic Inc or Guidant; Guidant Corporation, Santa Clara, Calif). The target coronary vessels were snared proximally with a silastic sling. An intracoronary shunt (Guidant Axius) was used only when there was hemodynamic compromise during construction of the anastomosis (usually the distal right coronary artery). Visualization was enhanced by using a surgical blower-mister device (Medtronic Clearview, Medtronic Inc). All patients had composite arterial grafts with complete avoidance of aortic manipulation.
TCD Monitoring
Continuous intraoperative monitoring was performed using a multifrequency Doppler system (Embodop, DWL). Dual frequency probes (2.0 and 2.5 MHz) were used to simultaneously insonate the middle cerebral arteries (MCAs) bilaterally. The probes were fixed to the transtemporal windows above the right and left zygomatic arches using a specifically designed head brace. The MCA insonation depth was set between 45 and 55 mm with a sample volume of 13 mm. An additional 2.0 MHz insonation reference gate was set 15 mm superficial to the MCA insonation gate. This reference gate serves for the online rejection of artifacts because the latter are identified when HITS are detected in both gates (MCAs and reference gates) simultaneously or with a time delay of less than 4 milliseconds. This multifrequency system (2.5 MHz and 2.0 MHz) also differentiates between solid and gaseous microemboli. Solid microemboli reflect more ultrasound at higher than at lower frequencies, contrary to what occurs in the case of gaseous microemboli. The differentiation occurs online during monitoring, and the data are recorded on a computer hard drive that also allows off-line analysis to be performed.
Statistical Analysis
Patient characteristics are presented as mean Ϯ SD. Normally distributed data were compared using the Student t test. Categoric variables were compared using the 2 test. The number of HITS is presented as median and interquartile ranges. Because the data are not normally distributed, the nonparametric Kruskal-Wallis test was used to compare the difference in microembolization among the 3 groups.
Results
Patient characteristics are summarized in Table 1 .
Only around 10% of all HITS were microemboli, with the remaining 90% being rejected as artifacts. The median (interquartile range) number of microemboli was 40 (28-80) in the OPCABG group, 275 (199-472) in the ONCABG group, and 860 (393-1321) in the open procedure group (P Ͻ .01) ( Table 2) .
Solid microemboli accounted for 12% of all microemboli in the OPCABG group compared with 28% and 22% in the ONCABG and open procedure groups, respectively. The proportion of particulate microemboli was significantly higher in the on-pump groups compared with the OPCABG group (P Ͻ .05) ( Table 2 ).
In the on-pump group, the largest proportion of microemboli occurred during aortic manipulation (cannulation, decannulation, and application and removal of crossclamp and sideclamp (Figure 1) , accounting for 56% of the total, whereas 24% occurred during CPB (Table 3 ). The extent of gaseous and solid microembolization during the different stages of OPCABG, ONCABG, and open procedures is shown in Figures 2, 3 , and 4.
Discussion
Our study adds to the understanding of the pathophysiology of microemboli during cardiac surgery by using a new generation of TCD that automatically rejects artifacts and discriminates between gaseous and solid microemboli.
Comparison of cerebral microembolization in on-pump versus off-pump procedures has been reported. 10 However, this is the first report contrasting the nature of microemboli in ONCABG, OPCABG, and open procedures. In comparison with OPCABG, there is a 7-fold increase in microemboli in ONCABG and a 22-fold increase in open procedures. Furthermore, the proportion of solid microemboli was significantly reduced in the off-pump group.
Cerebral microemboli have been implicated in the pathogenesis of cognitive decline after CPB for more than a decade. 7, 11, 12 Various reports have demonstrated a positive association between the number of intraoperative cerebral microemboli detected by TCD and postoperative neuropsychologic dysfunction. In addition, autopsy studies have reported large numbers of lipid microemboli in the brains of patients dying after cardiac surgery that correlated with the duration of CPB. 13 A recent report demonstrated a significant reduction in the incidence of neuropsychologic impairment with avoidance of CPB.
14 Our study demonstrates the remarkable reduction in the degree of microembolization, both gas and solid, during OPCABG. This may account for the difference in neuropsychologic impairment reported between patients undergoing on-pump and off-pump procedures. 10, 14 The clinical consequences, however, may be equally dependent on the nature and number of microemboli identified using TCD.
Particulate microemboli are generally assumed to be potentially the most damaging. Until recently, it was not possible to distinguish between gaseous and solid microemboli. We used a recently validated method 9 to identify the variation in the degree and nature of microembolism during different cardiac surgery procedures. In addition, this technique allows automatic online rejection of artifacts, whereas previously the human observer was regarded as the "gold standard." Gaseous microemboli as small as 3 m and solid microemboli of 80 m in diameter can be reliably detected. 9 The demonstration of the increase in particulate embolic load to the brain of patients undergoing CPB highlights the potential of the latter for causing cerebral injury, which is most likely to be evident in higher risk patients. The avoidance of CPB and aortic manipulation in the latter group has been shown to significantly reduce postoperative neurologic complications. 15, 16 What is the source of microemboli during OPCABG? Although microemboli can be detected in the cerebral circulation using TCD, the origin of these microemboli remains speculative. In the case of total arterial revascularization using composite arterial grafts (a "no-touch" aortic technique), a likely source of gaseous microemboli is air entering the coronary artery during arteriotomy and being returned to the left ventricle through the Thebesian veins. Another potential source of gas microemboli is through injections into central venous lines. Microemboli in the right side of the heart may then enter the systemic circulation by paradoxic embolism through a patent foramen ovale (present in up to 35% of the healthy population 17 ) or after transpulmonary passage. These mechanisms may also explain why cerebral microembolization occurs during major non-cardiac surgery procedures, particularly during major orthopedic operations. 18, 19 Particulate microemboli may form within the heart, particularly the left atrial appendage and left ventricle. In on-pump cases, they can form within the bypass circuit if anticoagulation is inadequate. Cholesterol microemboli probably arise from the atherosclerotic aorta during manipulation, 20 whereas use of the cardiotomy suction and denaturation of proteins may result in lipid microembolization during CPB. 21 Furthermore, platelet and blood cell aggregation occurring during CPB may add to this microembolic load. Gaseous microemboli may enter the circulation during flushing and filling of coronary conduits, at initiation of CPB, through the bypass circuit after blood sampling and injection of drugs, and during cardiac ejection after open procedures. 22 The increase in absolute numbers of gaseous microemboli during open procedures is consistent with transesophageal echocardiographic findings even after vigorous de-airing procedures. 23 It must be noted, however, that differentiation and quantitation of HITS is difficult when a large number of microemboli pass through the sample volume simultaneously such as after removal of the aortic crossclamp or sideclamp. 8 This, however, serves to underestimate the benefits of OPCABG in which there is a lack of such embolic showers entering the sample volume simultaneously.
Cerebral injury remains one of the most important causes of adverse outcomes after cardiac surgery. It particularly affects elderly patients and those with other comorbidities and is more common and severe after cardiac operations performed using CPB.
14 As a progressively older and sicker population undergoes both cardiac and noncardiac surgery procedures, the scale of the problem is likely to increase. Indeed, we and others have documented that advanced age is the strongest predictor of postoperative neurocognitive impairment.
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Conclusion
Cerebral embolization remains a problem during CPB. This can be minimized by performing off-pump surgery with avoidance of aortic manipulation. The ability to reliably discriminate the nature of cerebral microemboli has an important potential role in targeting various prevention strategies to improve neurologic outcome after cardiac operations, particularly de-airing after open procedures.
